ATLANTA--(BUSINESS WIRE)--MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, announced today that the unregistered private placement of 25,100,000 units referenced in its news release of July 6, 2007 has closed. The units were offered at a price of $0.50 per unit for gross proceeds of $12.55 million. Each unit consists of one share of common stock and one-half of one share purchase warrant exercisable at a price of $0.55 per share for a period of five years.
